W Michael Bonney
Affiliations
- Executive Chair at Alnylam Pharmaceuticals Inc. (ALNY), 2021-08-03
- Director at Bristol Myers Squibb Co (BMY), 2021-06-14
- Director at Magenta Therapeutics Inc. (MGTA), 2021-06-03
- Director at Kaleido Biosciences Inc. (KLDO), 2020-07-01
- Director at Sarepta Therapeutics Inc. (SRPT), 2020-02-29
- at Celgene Corp (CELG), 2019-11-22
- Director at Syros Pharmaceuticals Inc. (SYRS), 2019-06-12
- Director at Global Blood Therapeutics Inc. (GBT), 2016-06-18
- Director at Tekla World Healthcare Fund (THW), 2015-08-18
- Director at Nps Pharmaceuticals Inc (NPSP), 2015-02-25
- Chief Executive Officer at Cubist Pharmaceuticals Inc (CBST), 2015-01-21
- Director at Tekla Healthcare Opportunities Fund (THQ), 2014-07-29
- Director at H&q Life Sciences Investors (HQL), 2014-06-30
- Director at H&q Healthcare Investors (HQH), 2014-06-30
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| BMY | $58.90 | 88 | Director | 7,189 | 2019-12-04 | Filing | |
| SRPT | $86.74 | 2,000 | Director | 7,051 | 2019-09-09 | Filing | |
| KLDO | $14.65 | 2,555 | Officer, Director | 1,008,523 | 2019-02-28 | Filing | |
| KLDO | $13.95 | 68,965 | Officer, Director | 1,005,968 | 2019-02-28 | Filing | |
| ALNY | $58.36 | 2,000 | Director | 4,000 | 2016-03-09 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| CBST | $67.50 | 3,036 | Officer, Director | 175,859 | 2014-05-15 | Filing | |
| CBST | $69.00 | 3,840 | Officer, Director | 172,645 | 2014-05-14 | Filing | |
| CBST | $81.25 | 100,000 | Officer, Director | 168,485 | 2014-02-27 | Filing | |
| CBST | $75.60 | 3,112 | Officer, Director | 168,485 | 2014-02-20 | Filing | |
| CBST | $50.00 | 60,000 | Officer, Director | 161,518 | 2013-05-20 | Filing |